#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA645813	B	Compound was evaluated for inactivation of 156A mutant AGT		2	ALA1133481	single protein format	Scientific Literature
2.	ALA645814	B	Compound was evaluated for inactivation of G160R mutant AGT		1	ALA1133481	single protein format	Scientific Literature
3.	ALA645815	B	Compound was evaluated for inactivation of P140K mutant AGT		1	ALA1133481	single protein format	Scientific Literature
4.	ALA645816	B	Compound was evaluated for inactivation of Wild type AGT		2	ALA1133481	single protein format	Scientific Literature
5.	ALA645817	B	Compound was evaluated for inactivation of Y158H mutant AGT		2	ALA1133481	single protein format	Scientific Literature
6.	ALA645818	B	Compound was evaluated for inactivation of G160R mutant AGT		1	ALA1133481	single protein format	Scientific Literature
7.	ALA645819	B	Compound was evaluated for inactivation of P140K mutant AGT		1	ALA1133481	single protein format	Scientific Literature
8.	ALA645820	B	Inhibition of AGT activity to 50% of control rate in HT-29 cell extract		24	ALA1133481	cell-based format	Scientific Literature
9.	ALA645821	B	concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract.		9	ALA1133481	cell-based format	Scientific Literature
10.	ALA645822	B	concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract; ND denotes not determined.		1	ALA1133481	cell-based format	Scientific Literature
11.	ALA645823	B	concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract; ND means not determined.		2	ALA1133481	cell-based format	Scientific Literature
12.	ALA645824	B	concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells		3	ALA1133481	cell-based format	Scientific Literature
13.	ALA645825	B	concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells.		2	ALA1133481	cell-based format	Scientific Literature
14.	ALA645826	B	concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells.		4	ALA1133481	cell-based format	Scientific Literature
15.	ALA645827	B	Concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells; ND denotes no data	Homo sapiens	23	ALA1133481	cell-based format	Scientific Literature
16.	ALA884711	B	Percent AGT inactivation in HT-29 cell extract at 1 mM	Homo sapiens	11	ALA1133481	cell-based format	Scientific Literature
17.	ALA645828	B	Percent of AGT inactivation in HT-29 cell extract at 1 mM concentration.		8	ALA1133481	single protein format	Scientific Literature
18.	ALA644183	B	Percent of AGT inactivation in HT-29 cell extract at 1 mM concentration; ND denotes no data.	Homo sapiens	18	ALA1133481	cell-based format	Scientific Literature
19.	ALA636819	B	concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells.	Homo sapiens	1	ALA1133481	cell-based format	Scientific Literature
20.	ALA642174	B	In vitro inhibition of human alkyl transferase in HT-29 cell-free extracts.		17	ALA1126093	cell-based format	Scientific Literature